Home / Companies / Bio-Rad Laboratories, Inc. / 21 Apr 2026
Bio-Rad Laboratories, Inc.: meeting of 21 Apr 2026
Votes reported on Form N-PX, item by item
594 Form N-PX filers reported votes at the Bio-Rad Laboratories, Inc. meeting of 21 Apr 2026. Their records fall into 5 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
2 nominees; 73.0% of reported votes for; 56 filers withheld from or voted against at least one nominee.
784 vote records from 182 filers. 42 of the 180 filers that marked the item either way voted against management. 2 filers reported this item without a management mark.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
920 vote records from 589 filers. 54 of the 562 filers that marked the item either way voted against management. 27 filers reported this item without a management mark.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
391 vote records from 182 filers. 2 of the 180 filers that marked the item either way voted against management. 2 filers reported this item without a management mark.
COMPENSATIONIssuer
COMPENSATION: management items
Management items in this category are shown together; filers word and number them differently.
418 vote records from 188 filers. 2 of the 185 filers that marked the item either way voted against management. 3 filers reported this item without a management mark.
SHAREHOLDER RIGHTS AND DEFENSESSecurity holder
Stockholder proposal regarding dual class capital structure.
388 vote records from 179 filers. 165 of the 177 filers that marked the item either way voted against management. 2 filers reported this item without a management mark.
How the largest families voted
| Family | 1. Directors | 2. Say-on-pay | 3. Auditor | 5. Proposal |
|---|---|---|---|---|
| Vanguard | For | For | For | For * |
| BlackRock and iShares | For | For | For | For * |
| Fidelity | Against * | For | For | For * |
| Dimensional | For | For | For | For * |
| State Street and SPDR | Against * | For | For | For * |
| American Century | For | For | For | For * |
| Franklin Templeton | Against * | For | For | For * |
| Invesco | For | Against * | For | For * |
| Equitable | For | For | For | For * |
| Charles Schwab | For | For | For | For * |
| Nuveen and TIAA | For | For | For | For * |
| ProShares and ProFunds | For | For | For | For * |
| John Hancock and Manulife | For | For | For | For * |
| Morgan Stanley, Eaton Vance and Calvert | Against * | For | For | For * |
| J.P. Morgan | For | For | For | For * |
| Goldman Sachs | For | For | For | For * |
| WisdomTree | For | Against * | For | For * |
| PGIM and Prudential | For | For | For | For * |
| Jackson National funds | For | Against * | For | For * |
| Northern Trust and FlexShares | For | For | For | For * |
| SEI | Against * | For | For | For * |
| T. Rowe Price | Against * | For | For | For * |
| Thrivent | For | For | For | For * |
| Lincoln Financial | For | For | For | For * |
| Voya | Against * | For | For | For * |
| First Trust | For | For | For | For |
| Russell Investments | Against * | For | For | For * |
| Nationwide | For | For | For | For * |
| Victory Capital | For | For | For | For * |
| Brighthouse Funds | For | For | For | For * |
| Guggenheim and Rydex | For | For | For | For * |
| Columbia Threadneedle | For | For | For | For * |
| BNY Mellon | For | Against * | For | For * |
| Principal | For | For | For | For * |
| Capital Group and American Funds | For | Against * | For | For * |
| Pacific Life funds | For | For | For | For * |
| MFS | For | For | For | For * |
| Transamerica | For | For | For | For * |
| Federated Hermes | For | For | For | For * |
| AllianceBernstein | No report | For | No report | No report |
| DWS | No report | For | No report | No report |
| PIMCO | For | For | For | For * |
| Allspring | For | For | For | For * |
| MassMutual | Against * | For | For | For * |
| Harbor Funds | For | For | For | For * |
| Neuberger Berman | No report | For | No report | No report |
| Natixis and Loomis Sayles | For | For | For | For * |
| Baird | No report | For | No report | No report |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Bio-Rad Laboratories, Inc. meeting?
594 Form N-PX filers reported votes at the meeting of 21 Apr 2026. On say-on-pay, 54 of 562 voted against management (9.6%). One proposal from security holders could be told apart in the filings. The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Bio-Rad Laboratories, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Bio-Rad Laboratories, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Bio-Rad Laboratories, Inc. with a meeting date within three days of 21 Apr 2026. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.